Contact Us

BUSINESS NEWS

Akeso Published Ivonescimab plus Ligufalimab as First-Line Treatment for PD-L1-Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma at ESMO 2024

Sep 17, 2024

Head-to-Head Phase 3 Trial Compared to Pembrolizumab Initiated HONG KONG,Sept. 15,2024-- At the 2024 European Society for Medical Oncology (ESMO) Conference,Akeso released the Phase 2 clinical results

Infinix Taps Porsche Dreamer Stories Featured Creator: Discover the ZERO 40 Series GoPro Mode

Sep 17, 2024

Swim with Giants: Experience Whale Sharks Like Never Before with This Pro-Level Vlog Smartphone! HONG KONG,Sept. 14,2024-- What is it like to swim alongside the largest fish on Earth? Now,moments like

Alphamab Oncology Presented the Latest Clinical Data from Two Studies on Anti-HER2 Bispecific ADC JSKN003 at the ESMO Congress 2024

Sep 17, 2024

SUZHOU,China,Sept. 16,2024--Alphamab Oncology (stock code: 9966.HK) announced that the latest clinical data from two studies on anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 were presente

FETC International's MD Dr. Y.C. Chang Honored with the "Master Entrepreneur Award" at APEA 2024

Sep 17, 2024

TAIPEI,Sept. 16,2024-- The Asia Pacific Enterprise Awards (APEA),one of the region\'s most prestigious recognitions for business leadership,held its 2024 awards ceremony on September 13 in Taipei. Af

Risen Energy Champions Environmental Stewardship for a Greener Future

Sep 17, 2024

NINGBO,China,Sept. 16,2024-- On September 20,World Cleanup Day 2024 kicks off during the Clean Up the World Weekend (CUW Weekend),themed "make room for life." Since joining the UN Global Com

Checkmate secures NZD 2.7 million in Seed funding to transform pre-employment screening

Sep 17, 2024

The company will use the funds to expand to US and Southeast Asia markets AUCKLAND,New Zealand,Sept. 17,2024-- Checkmate,the fast-growing provider of comprehensive pre-employment screening solutions,i

1 ... 247 248 249 250 251 252 253 ... 320